The NCI requires the use of the SEX-steroid hormone assay. The NCI proposes to test 695 samples. Total number of test samples will be performed across the base and option years.
Ended Purchase Order Awarded Last action
- Contract number
- 75N91023P00779
- Awardee
-
Universite Laval UEI QMALL67LLC74
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $205,025
Award facts
- Opportunity
-
- Association of sex steroid hormones and gallbladder cancer in Women Special Notice · 75N91023Q00137 · Posted Jul 19, 2023
- Contract value 100% obligated
- $205,025.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Universite Laval Research And Innovation Vice-Rector Division has been awarded a $205,025 firm fixed-price purchase order by the National Institutes of Health National Cancer Institute to conduct a sex-steroid hormone assay on 695 biospecimen samples. The purpose of the assay is to examine the association between sex hormones and gallbladder cancer in women. Key deliverables under the contract include running the assay, delivering encrypted electronic test results to NIH, and returning residual samples. The period of performance is from September 2023 to March 2025. No set-aside designation or subcontractors were identified. The National Cancer Institute seeks to advance cancer research through contracts such as this to increase understanding of relationships between biological factors and certain types of cancer.
Quick answers
Who was awarded contract 75N91023P00779?
75N91023P00779 was awarded to Universite Laval by National Cancer Institute (National Institutes of Health) on September 29, 2023.
How much is contract 75N91023P00779 worth?
The government has obligated $205,025 on 75N91023P00779.
Was contract 75N91023P00779 competed?
The extent of competition for 75N91023P00779 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award